insugen-n (nph) insulin injection isophane 100iuml
biocon sdn bhd - insulin human -
insugen-r (regular) insulin injection soluble 100iuml
biocon sdn bhd - insulin human -
insugen-3070 (biphasic) insulin injection biphasic isophane 100iuml
biocon sdn bhd - insulin human -
insulin aspart sanofi
sanofi winthrop industrie - insulin aspart - diabetes mellitus - drugs used in diabetes - insulin aspart sanofi is indicated for the treatment of diabetes mellitus in adults, adolescents and children aged 1 year and above.
kirsty insulin aspart injection (rdna origin) 100uml pre-filled pen
biocon sdn bhd - insulin aspart -
insulin human winthrop
sanofi-aventis deutschland gmbh - insulin human - diabetes mellitus - drugs used in diabetes - diabetes mellitus where treatment with insulin is required. insulin human winthrop rapid is also suitable for the treatment of hyperglycaemic coma and ketoacidosis, as well as for achieving pre-, intra- and postoperative stabilisation in patients with diabetes mellitus.
prozinc- protamine zinc recombinant human insulin injection
boehringer ingelheim animal health usa inc. - insulin human (unii: 1y17cti5sr) (insulin human - unii:1y17cti5sr) - insulin human 40 [iu] in 1 ml - prozinc is contraindicated in cats sensitive to protamine zinc recombinant human insulin or any other ingredients in prozinc. prozinc is contraindicated during episodes of hypoglycemia. prozinc is contraindicated in dogs sensitive to protamine zinc recombinant human insulin or any other ingredients in prozinc. prozinc is contraindicated during episodes of hypoglycemia.
humulin n suspension
eli lilly canada inc - insulin nph human dna origin - suspension - 100unit - insulin nph human dna origin 100unit - insulins
humulin 30/70 (insulin human biosynth inj) suspension
eli lilly canada inc - insulin; insulin isophane (nph) - suspension - 30unit; 70unit - insulin 30unit; insulin isophane (nph) 70unit - insulins
apidra solostar insulin glulisine (rbe) 100iu/ml 3ml solution for injection injector pen
sanofi-aventis australia pty ltd - insulin glulisine, quantity: 3.49 mg/ml - injection, solution - excipient ingredients: water for injections; sodium chloride; metacresol; polysorbate 20; trometamol; hydrochloric acid; sodium hydroxide - apidra is indicated for the treatment of type 1 and type 2 diabetes mellitus in adults and children of 4 years or above who require insulin for the control of hyperglycaemia.